Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -12,436 | N/A | N/A |
| Depreciation Amortization | -115 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,034 | N/A | N/A |
| Other Working Capital | -1,020 | N/A | N/A |
| Other Operating Activity | 27 | 0 | 0 |
| Operating Cash Flow | $-12,510 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -7,234 | N/A | N/A |
| PPE Investments | -7 | N/A | N/A |
| Investing Cash Flow | $-7,241 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 26 | N/A | N/A |
| Other Financing Activity | 24,960 | 0 | 0 |
| Financing Cash Flow | $24,986 | $N/A | $N/A |
| Beginning Cash Position | 12,266 | N/A | N/A |
| End Cash Position | 17,501 | N/A | N/A |
| Net Cash Flow | $5,235 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -12,510 | N/A | N/A |
| Capital Expenditure | -7 | N/A | N/A |
| Free Cash Flow | -12,517 | 0 | 0 |